ACKR3 and laryngotracheoesophageal cleft: Our findings indicate that circulating serum hsa_circ_0072309, which acts via miR‐100/ACKR3 signaling, could be a new diagnostic and prognostic biomarker and a possible therapeutic target for LC metastatic transformation.